StockData
Quantum Biopharma Ltd. logo

Quantum Biopharma Ltd. (QNTM) stock

QNTMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 26, 2026Score 1/30
$1.52−0.07 (-4.40%)

Close on Nov 18, 2026Market cap $5.91MP/E –Yield –

Quantum Biopharma operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Quantum Biopharma's operating income for the twelve months ending Jun 30, 2026 was -$12.31M. For fiscal 2025 it was -$15.30M. The highest annual figure on record is -$15.30M in fiscal 2025.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$15.30M–
FY2024Dec 31, 2024-$16.14M–
FY2023Dec 31, 2023-$23.79M–
FY2022Dec 31, 2022-$27.43M–
FY2021Dec 31, 2021-$33.74M–
FY2020Dec 31, 2020-$30.69M–
FY2019Dec 31, 2019-$22.48M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$2.29M–
Q1 FY2026Mar 31, 2026-$2.97M–
Q4 FY2025Dec 31, 2025-$2.37M–
Q3 FY2025Sep 30, 2025-$4.68M–
Q2 FY2025Jun 30, 2025-$4.85M–
Q1 FY2025Mar 31, 2025-$3.40M–
Q4 FY2024Dec 31, 2024-$6.24M–
Q3 FY2024Sep 30, 2024-$4.18M–
Q2 FY2024Jun 30, 2024-$3.46M–
Q1 FY2024Mar 31, 2024-$2.26M–
Q4 FY2023Dec 31, 2023-$1.80M–
Q3 FY2023Sep 30, 2023-$3.31M–

More Quantum Biopharma figures

See a number that looks wrong?